JUL 2024 TO 30 SEP 2024Net sales increased by approximately 11% to KSEK 5,481 (4,954) MRR in September was KUSD 209 (151)EBIT was KSEK -3,540 (-3,618) EPS before dilution ...
PUBLICATION This information is information that RightBridge Ventures Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submited for publication ...
BUENOS AIRES, ARGENTINA / ACCESSWIRE / November 29, 2024 / NOA Lithium Brines Inc. (TSXV:NOAL) ("NOA" or the "Company") is pleased to announce that further to the Company's press release dated October ...
On 29th of November 2024, Secop Group Holding GmbH announced its financial results for the third quarter 2024. In Q3-2024, Secop achieved an Internal Adjusted EBITDA on the same level as in the previo ...
Fragbite Group AB (publ) ("The Company") held an Extraordinary General Meeting on 4 November 2024, at which it was resolved to carry out a reverse split of the Company's shares by 1:500, which entails ...
Gapwaves announces the termination of the joint development agreement with Bosch entered into between the parties in July 2022. The parties have collaborated since 2021, ...
Brazil Potash Corp. ("Brazil Potash" or the "Company") announced today the pricing of its initial public offering (the "IPO") of 2,000,000 of its common ...
AFYREN (Paris:ALAFY), a greentech company that offers manufacturers biobased, low-carbon ingredients produced using unique fermentation technology based on a completely circular ...
Das Unternehmen startet das Projekt "Sailing into the Future. Together" neu und legt dabei den Schwerpunkt auf inklusives Segeln Drei Jahre intensiver Arbeit, 25.000 Meilen Rennen, fünf Atlantiküberqu ...
Altasciences ist stolz darauf, Metsera, Inc., ein biopharmazeutisches Unternehmen der klinischen Phase, das die nächste Generation von Medikamenten gegen Fettleibigkeit und Stoffwechselerkrankungen ...
Disclosure in trading in own shares Regulatory News: ELIOR GROUP (Paris:ELIOR): In accordance with the authorization given by the combined shareholders' general meeting on February 28, 2024 ...
Advicenne(Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering ...